Financials

  • Market Capitalization 38.33 M
  • Employee 17
  • Founded 2009
  • CEO N/A
  • Website www.renovorx.com
  • Headquarter Delaware, United States
  • FIGI BBG005XWWZK6
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.06
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4373
ACTU
Actuate Therapeutics, Inc. - Common stock
1.73 USD+15.33%+16.89%-15.61%-57.60%41.39 M USD
4382
GRCE
Grace Therapeutics, Inc. - Common Stock
2.46 USD+1.23%-1.60%+10.81%-38.19%40.03 M USD
4394
NNVC
NanoViricides, Inc. Common Stock
1.77 USD+7.27%+19.59%+24.65%+75.23%38.32 M USD
4398
ALGS
Aligos Therapeutics, Inc. - Common stock
6.11 USD-3.93%+3.21%+20.28%-37.59%37.81 M USD

Haberler